Ousted HHS vaccine expert felt pressure to rush possible Covid-19 treatment after Trump spoke to Oracle boss Larry Ellison

Welcome to the Precious Metals Bug Forums

Welcome to the PMBug forums - a watering hole for folks interested in gold, silver, precious metals, sound money, investing, market and economic news, central bank monetary policies, politics and more. You can visit the forum page to see the list of forum nodes (categories/rooms) for topics.

Why not register an account and join the discussions? When you register an account and log in, you may enjoy additional benefits including no Google ads, market data/charts, access to trade/barter with the community and much more. Registering an account is free - you have nothing to lose!

Goldhedge

GIM2 Refugee
Moderator
Messages
10,196
Reaction score
7,849
Points
238
Old but still interesting

Ousted HHS vaccine expert felt pressure to rush possible Covid-19 treatment after Trump spoke to Oracle boss Larry Ellison​

PUBLISHED THU, APR 23 20201:09 PM EDTUPDATED THU, APR 23 2020

KEY POINTS
  • A federal vaccine expert who was ousted from his post this week felt pressured to rush out expanded access to a potential coronavirus treatment after President Trump discussed the drug with Oracle’s Larry Ellison, NBC News reported.
  • A source told NBC News that Dr. Rick Bright was told to put in place a national program geared to expanding access to the drug hydroxychloroquine after Ellison and the president spoke about it.
A top federal vaccine expert who was ousted from his post this week felt pressured to rush out expanded access to a potential treatment for coronavirus patients after President Donald Trump discussed the drug with Larry Ellison, chairman of tech giant Oracle, NBC News reported Thursday.

The report comes a day after the expert, Rick Bright, went public with a bombshell statement saying he was removed from leading a federal agency heavily involved in coronavirus response efforts after he “resisted efforts to fund potentially dangerous drugs promoted by those with political connections.”

And it comes on the same day that a House committee chairman called for an investigation into Bright’s forced transfer from his post as director of the Biomedical Advanced Research and Development Authority, or BARDA, a unit of the U.S. Health and Human Services Department.

A source close to Bright who spoke with NBC News said that he was told to put in place a national program geared to expanding access to the drug hydroxychloroquine after Ellison, who has raised campaign funds for Trump, and the president spoke about it.


more
 
Back
Top Bottom